Clinical trial
Development of an Evaluation Method of Elderly Condition in Patient Receiving…
NCT00210249 · Institut Bergonié, Other · Completed
Key facts
| NCT number | NCT00210249 |
|---|---|
| Title | Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment |
| Official title | Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment . Geriatric Oncology Protocol in Aquitaine Country. |
| Acronym | PHRC2003 |
| Lead sponsor | Institut Bergonié, Other |
| Collaborators | Sanofi-Synthelabo Industry Aventis Pharmaceuticals Amgen Chugai Pharmaceutical Bristol-Myers Squibb |
| Status | Completed |
| Study type | Observational |
| Conditions | Lymphoma, Digestive System Diseases, Ovarian Diseases, Pulmonary Disease, Prostatic Disease, Bladder Disease |
| Enrollment | 364 |
| Start date | Sep 1, 2002 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 4, 2022 |
| Countries | France |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: